STRS Ohio’s Krystal Biotech KRYS Stock Holding History

STRS Ohio’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53M	Buy	6,800 +400	+6%	+$120K	0.01%	529
2026 Q1	$1.65M	Sell	6,400 -100	-2%	-$26.6K	0.01%	606
2025 Q4	$1.6M	Sell	6,500 -900	-12%	-$189K	0.01%	606
2025 Q3	$1.31M	Hold	7,400	–	–	﹤0.01%	624
2025 Q2	$1.02M	Buy	7,400 +500	+7%	+$73.4K	﹤0.01%	910
2025 Q1	$1.24M	Sell	6,900 -400	-5%	-$67.3K	0.01%	772
2024 Q4	$1.14M	Buy	7,300 +2,300	+46%	+$408K	﹤0.01%	816
2024 Q3	$910K	Buy	5,000 +800	+19%	+$154K	﹤0.01%	941
2024 Q2	$771K	Buy	4,200 +2,000	+91%	+$336K	﹤0.01%	979
2024 Q1	$391K	Sell	2,200 -3,400	-61%	-$472K	﹤0.01%	1352
2023 Q4	$694K	Sell	5,600 -800	-13%	-$88.7K	﹤0.01%	1065
2023 Q3	$742K	Buy	6,400 +3,500	+121%	+$427K	﹤0.01%	1020
2023 Q2	$340K	Buy	2,900 +1,600	+123%	+$163K	﹤0.01%	1432
2023 Q1	$104K	Sell	1,300 -2,800	-68%	-$220K	﹤0.01%	1708
2022 Q4	$324K	Hold	4,100	–	–	﹤0.01%	1471
2022 Q3	$285K	Hold	4,100	–	–	﹤0.01%	1499
2022 Q2	$269K	Buy	4,100 +200	+5%	+$12.4K	﹤0.01%	1510
2022 Q1	$259K	Hold	3,900	–	–	﹤0.01%	1642
2021 Q4	$272K	Hold	3,900	–	–	﹤0.01%	1647
2021 Q3	$203K	Hold	3,900	–	–	﹤0.01%	1764
2021 Q2	$265K	Buy	+3,900	New	+$272K	﹤0.01%	1739
2020 Q3	–	Sell	-2,300	Closed	-$95K	–	2241
2020 Q2	$95K	Hold	2,300	–	–	﹤0.01%	1799
2020 Q1	$99K	Hold	2,300	–	–	﹤0.01%	1685
2019 Q4	$127K	Hold	2,300	–	–	﹤0.01%	1741
2019 Q3	$79K	Hold	2,300	–	–	﹤0.01%	1801
2019 Q2	$92K	Buy	+2,300	New	+$75.2K	﹤0.01%	1824

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

STRS Ohio's KRYS Position: Q2 2026 in Review

STRS Ohio increased its Krystal Biotech (KRYS) stake by 6.3% in Q2 2026, buying an estimated $120K and bringing the position to 6,800 shares worth $2.53M. The position accounts for 0.01% of the portfolio, ranked #529.

STRS Ohio first reported a position in KRYS in Q2 2019 and has held it in 26 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

STRS Ohio held 6,800 shares of Krystal Biotech worth $2.53M as of Q2 2026.
STRS Ohio bought 400 Krystal Biotech shares in Q2 2026, an estimated $120K.
Krystal Biotech made up 0.01% of STRS Ohio's portfolio in Q2 2026, its #529 holding.
STRS Ohio first reported a position in Krystal Biotech in Q2 2019 and has held it in 26 quarters since.
424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.